The triglyceride high-density cholesterol-glucose body index as a superior metabolic biomarker for incident type 2 diabetes in normoglycemic subjects: a large-scale cohort study
- 1Department of Anesthesiology, Jieyang People’s Hospital
- 2First Clinical Medical College, Guangdong Medical University
Abstract
Background: The triglyceride high-density cholesterol-glucose body index (TyHGB) is a novel composite metabolic index, but evidence regarding its association with incident type 2 diabetes mellitus (T2DM) and predictive performance is lacking.
Methods: This was a retrospective cohort study based on a secondary analysis of publicly available data from the NAGALA (NAfld in the Gifu Area, Longitudinal Analysis) study. This study cohort included 15,453 participants with normoglycemia at baseline. Cox proportional hazards regression was used to evaluate the association between TyHGB and incident T2DM. Restricted cubic splines and threshold effect analyses were performed to explore nonlinear relationships. Time-dependent receiver operating characteristic (ROC) curves were used to assess the predictive performance of TyHGB.
Results: Over a median follow-up of 5.4 years, 373 participants developed T2DM. After multivariable adjustment, each unit increase in TyHGB was associated with a 36% higher risk of T2DM (hazard ratio [HR] = 1.36, 95% confidence interval [CI]: 1.27 – 1.45). Compared with the lowest quartile, the highest quartile had a 5.68-fold risk (HR = 5.68, 95% CI: 2.84 – 11.36). A nonlinear relationship was identified, with an inflection point at TyHGB = 6.748. Time-dependent ROC analysis showed that TyHGB consistently demonstrated the highest area under the curve (AUC) for predicting incident diabetes at 3, 5, and 10 years of follow-up compared with traditional indices.
Conclusions: TyHGB is an independent risk factor for incident T2DM with a threshold effect. It demonstrates superior long-term predictive ability compared with traditional indices and may serve as a simple, cost-effective tool for diabetes risk stratification in large-scale community screening and primary care, particularly in resource-limited settings.
Related
- Association of the triglyceride-to-high-density lipoprotein cholesterol ratio with kidney stone status: cross-sectional and machine-learning analyses
- Underestimation of Low-Density Lipoprotein Cholesterol (LDL-C) Using the Friedewald Equation at Higher Triglyceride Levels: Evidence From a Method-Comparison Study
- Triglyceride-rich lipoprotein cholesterol is elevated in liver transplant recipients and associated with post-transplant diabetes
- Association Between Triglyceride-glucose Index, Neutrophil to High-density Lipoprotein Cholesterol Ratio and Atrial Fibrillation: A Retrospective Study in China.
- Triglyceride–high-density lipoprotein cholesterol–glucose–body mass index predicts 28-day all-cause mortality in critically ill patients with heart failure
BibTeX
@article{zhang2026triglyceride,
title = {{The triglyceride high-density cholesterol-glucose body index as a superior metabolic biomarker for incident type 2 diabetes in normoglycemic subjects: a large-scale cohort study}},
author = {Longsheng Zhang and Huankai Zhang and Zhiliang Huang and Renzhe Lin and Zitian Luo and Kaihong Zhang and Shujun Ye and Duo Yang},
journal = {Frontiers in Endocrinology},
year = {2026},
month = oct,
doi = {10.3389/fendo.2026.1914673},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1914673/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The triglyceride high-density cholesterol-glucose body index as a superior metabolic biomarker for incident type 2 diabetes in normoglycemic subjects: a large-scale cohort study
AU - Longsheng Zhang
AU - Huankai Zhang
AU - Zhiliang Huang
AU - Renzhe Lin
AU - Zitian Luo
AU - Kaihong Zhang
AU - Shujun Ye
AU - Duo Yang
PY - 2026
DA - 2026/10/13
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1914673
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1914673/full
AB - Background: The triglyceride high-density cholesterol-glucose body index (TyHGB) is a novel composite metabolic index, but evidence regarding its association with incident type 2 diabetes mellitus (T2DM) and predictive performance is lacking. Methods: This was a retrospective cohort study based on a secondary analysis of publicly available data from the NAGALA (NAfld in the Gifu Area, Longitudinal Analysis) study. This study cohort included 15,453 participants with normoglycemia at baseline. Cox proportional hazards regression was used to evaluate the association between TyHGB and incident T2DM. Restricted cubic splines and threshold effect analyses were performed to explore nonlinear relationships. Time-dependent receiver operating characteristic (ROC) curves were used to assess the predictive performance of TyHGB. Results: Over a median follow-up of 5.4 years, 373 participants developed T2DM. After multivariable adjustment, each unit increase in TyHGB was associated with a 36% higher risk of T2DM (hazard ratio [HR] = 1.36, 95% confidence interval [CI]: 1.27 – 1.45). Compared with the lowest quartile, the highest quartile had a 5.68-fold risk (HR = 5.68, 95% CI: 2.84 – 11.36). A nonlinear relationship was identified, with an inflection point at TyHGB = 6.748. Time-dependent ROC analysis showed that TyHGB consistently demonstrated the highest area under the curve (AUC) for predicting incident diabetes at 3, 5, and 10 years of follow-up compared with traditional indices. Conclusions: TyHGB is an independent risk factor for incident T2DM with a threshold effect. It demonstrates superior long-term predictive ability compared with traditional indices and may serve as a simple, cost-effective tool for diabetes risk stratification in large-scale community screening and primary care, particularly in resource-limited settings.
SN - 1664-2392
ER -